The TrimRx Approach to Personalized Care We understand that every body is unique
Dr Amanda Lim, a consultant in the division of endocrinology at the National University Hospital, noted that previously, lifestyle interventions might result in weight loss of around 3 to 8 per cent
Early GLP-1 manufacturers, including Novo Nordisk and Eli Lilly, originally developed the drug to help with blood sugar control in adults with type 2 diabetes, but weight loss has since become the primary driver of adoption, he says
Andrade S, Lobato CB, Machado M, et al
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial
In fact, making progress can depend on a complex combination of physical and psychological factors